首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Indications for prothrombin complex concentrates in massive transfusions.
【24h】

Indications for prothrombin complex concentrates in massive transfusions.

机译:凝血酶原复合物的适应症集中于大量输血。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A major hemorrhagic insult may require massive transfusions to maintain oxygen transport and hemostasis. Thus an adequate transfusion budget must consider losses, patient's blood volume, critical levels of laboratory parameters, replacement rates of coagulation factors from the extravascular space, and the efficacy of blood products. The substitution of large quantities of blood or red cell concentrates can induce and aggravate a complex haemostatic disorder. Some patients develop generalized microvascular bleeding. A transfusion regimen is described, which in our hands can reduce complications of massive transfusion. For hemostatic support, platelet concentrates and fresh frozen plasma are the treatment of choice. Localization and persistence of bleeding, hepatic disease, and vitamin K deficiency due to medication or intestinal malabsorption may require the supplementary use of prothrombin complex concentrates. Furthermore, antithrombin and fibrinogen concentrates may be indispensable.
机译:重大的出血性损伤可能需要大量输血以维持氧气的输送和止血。因此,充足的输血预算必须考虑损失,患者的血容量,实验室参数的临界水平,来自血管外空间的凝血因子的替代率以及血液制品的功效。大量血液或红细胞浓缩液的替代会诱发并加重复杂的止血病。一些患者发生全身性微血管出血。描述了一种输血方案,可以减少大量输血的并发症。对于止血,血小板浓缩液和新鲜冷冻血浆是首选治疗方法。由于药物或肠道吸收不良引起的出血,肝病和维生素K缺乏的局部性和持续性可能需要补充使用凝血酶原复合物浓缩物。此外,抗凝血酶和纤维蛋白原浓缩物可能是必不可少的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号